These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 18604550)
1. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement. Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202 [TBL] [Abstract][Full Text] [Related]
3. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
4. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease. Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285 [TBL] [Abstract][Full Text] [Related]
5. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107 [TBL] [Abstract][Full Text] [Related]
7. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
8. Serum leptin levels in patients with ocular and nonocular Behçet's disease. Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Probst K; Fijnheer R; Rothova A Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149 [TBL] [Abstract][Full Text] [Related]
10. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405 [TBL] [Abstract][Full Text] [Related]
11. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ambresin A; Tran T; Spertini F; Herbort C Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704 [TBL] [Abstract][Full Text] [Related]
12. An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Schönlein Purpura. Cayci FS; Ekim M; Egin Y; Gökce H; Yalcinkaya F; Ozcakar B; Akar N Pediatr Hematol Oncol; 2015 Mar; 32(2):115-22. PubMed ID: 24308805 [TBL] [Abstract][Full Text] [Related]
13. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity. Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829 [TBL] [Abstract][Full Text] [Related]
14. Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies. Ducros E; Mirshahi SS; Faussat AM; Mirshahi P; Dimicoli S; Tang R; Pardo J; Ibrahim J; Marie JP; Therwath A; Soria J; Mirshahi M Cancer Med; 2012 Oct; 1(2):261-7. PubMed ID: 23342274 [TBL] [Abstract][Full Text] [Related]
15. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum leptin concentration in Behçet's disease with ocular involvement. Kavuncu S; Koç F; Kurt M; Eryüksel B; Ortaç S; Ozdal P; Firat E Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1158-60. PubMed ID: 15906063 [TBL] [Abstract][Full Text] [Related]
17. Serum vitronectin levels in patients with Behçet's disease. Yalçındağ A; Uzun A; Nilüfer Yalçındağ F; Delibaş N Inflamm Res; 2012 Nov; 61(11):1241-6. PubMed ID: 22810367 [TBL] [Abstract][Full Text] [Related]
18. [Frequency and predictive factors of venous thrombosis in Behçet's disease]. Ha-Ou-Nou FZ; Essaadouni L Rev Med Interne; 2020 Sep; 41(9):578-582. PubMed ID: 32471710 [TBL] [Abstract][Full Text] [Related]
19. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease. Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Stearns-Kurosawa DJ; Swindle K; D'Angelo A; Della Valle P; Fattorini A; Caron N; Grimaux M; Woodhams B; Kurosawa S Blood; 2002 Jan; 99(2):526-30. PubMed ID: 11781234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]